Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study | AVESİS

Istanbul University Research Information System

Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study

Copy For Citation

Taher A. T., Cappellini M., Aydinok Y., Porter J., Karakas Z., Viprakasit V., ...More

AABB Annual Meeting, Florida, United States Of America, 22 - 25 October 2016, vol.56

Publication Type: Conference Paper / Summary Text
Volume: 56
City: Florida
Country: United States Of America
Istanbul University Affiliated: Yes